Latest respiratory tract infection news with live updates

Live respiratory tract infection news coverage of developments with the latest updates. Stay on top of latest respiratory tract infection news stories and find out what just happened, what is going on with respiratory tract infection. The latest real-time news updates and headlines on respiratory tract infection
Largest annual decrease in antibiotic use in community in two decades
Parent-collected nose swabs are as good as nurse-collected nose swabs at detecting respiratory infections in kids
Zinc shown to prevent symptoms and shorten duration of common cold and flu-like illnesses
Zinc might help to stave off respiratory infection symptoms and cut illness duration
Research reveals environmental and social factors contribute to higher rates of pneumonia in kids
Lactoferrin supplements could aid in recovery of COVID19
Real-world data shines light on impact of Covid on psoriasis patients
Largest trial of antibiotic amoxicillin for treating chest infections in children finds little effect
Saphnelo approved in Japan for systemic lupus erythematosus
Astellas’ and Pfizer’s XTANDI Reduced Risk of Death by 34% in Men with Metastatic Hormone-Sensitive Prostate Cancer
Scientists discover association between early lower respiratory tract infections and development of obstructive sleep apnea
XELJANZ Receives Marketing Authorization in European Union for Treatment of Active Polyarticular Juvenile Idiopathic Arthritis
36 per cent drop in antibiotic prescribing following Covid restrictions
Antibiotic resistance is global health challenge that can’t be ignored
Pfizer Announces Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitinib in Alopecia Areata
Children’s Hospital of Philadelphia researchers identify approach for potential nontypeable haemophilus influenzae vaccine
Saphnelo approved in US for moderate to severe systemic lupus erythematosus
Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ Filings
Tezepelumab regulatory submission accepted and granted FDA Priority Review
Refugee health challenges remain high amid COVID-19
Nirsevimab MEDLEY Phase II/III trial demonstrated favourable safety and tolerability profile in infants
In many cases, multiple sclerosis starts long before diagnosis
Researchers identify gene responsible for increased risk of infantile fragility
Dstl research behind trial of new blood test to predict sepsis
Very high use of antibiotics in COVID-19 treatment could be reduced
Anifrolumab showed benefit across different measures of skin and joint disease activity
WFP ramps up support to Yemen’s famine risk areas
Reimagining Global Research in a Pandemic
Global Therapeutics fined $119,880 for alleged unlawful advertising of complementary medicines
Nirsevimab MELODY Phase III trial met primary endpoint of reducing RSV lower respiratory tract infections
Link between COVID-19 infection and subsequent mental health and neurological conditions found
Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for Treatment of Moderate to Severe Atopic Dermatitis
TB vaccine may protect newborns against other infectious diseases
‘Toxic mix’ imperils lives of under-fives with acute malnutrition
Acute malnutrition threatens half of children under five in Yemen in 2021: UN
Pfizer shares co-primary endpoint results
Why People Overuse Antibiotics
LLNL and United Kingdom company to collaborate on development of universal coronavirus vaccine
Honey better than usual care for easing respiratory symptoms, especially cough
Identifying risk of unplanned emergency department transfer in aged care